BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34059508)

  • 1. Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.
    Orouji E; Raman AT; Singh AK; Sorokin A; Arslan E; Ghosh AK; Schulz J; Terranova C; Jiang S; Tang M; Maitituoheti M; Callahan SC; Barrodia P; Tomczak K; Jiang Y; Jiang Z; Davis JS; Ghosh S; Lee HM; Reyes-Uribe L; Chang K; Liu Y; Chen H; Azhdarinia A; Morris J; Vilar E; Carmon KS; Kopetz SE; Rai K
    Gut; 2022 May; 71(5):938-949. PubMed ID: 34059508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
    Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
    Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
    Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
    Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
    BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Chromatin States Coupling with Key Transcription Factors in Colitis-Associated Colorectal Cancer.
    Chen L; Luo Z; Zhao C; Li Q; Geng Y; Xiao Y; Chen MK; Li L; Chen ZX; Wu M
    Adv Sci (Weinh); 2022 Aug; 9(23):e2200536. PubMed ID: 35712778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.
    Cohen AJ; Saiakhova A; Corradin O; Luppino JM; Lovrenert K; Bartels CF; Morrow JJ; Mack SC; Dhillon G; Beard L; Myeroff L; Kalady MF; Willis J; Bradner JE; Keri RA; Berger NA; Pruett-Miller SM; Markowitz SD; Scacheri PC
    Nat Commun; 2017 Feb; 8():14400. PubMed ID: 28169291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features.
    Chen CY; Morris Q; Mitchell JA
    BMC Genomics; 2012 Apr; 13():152. PubMed ID: 22537144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells.
    Jägle S; Busch H; Freihen V; Beyes S; Schrempp M; Boerries M; Hecht A
    PLoS Genet; 2017 Nov; 13(11):e1007109. PubMed ID: 29155818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
    Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
    Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
    Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
    Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
    Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
    Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
    Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing Genetic Regulatory Elements in Ovine Tissues.
    Davenport KM; Massa AT; Bhattarai S; McKay SD; Mousel MR; Herndon MK; White SN; Cockett NE; Smith TPL; Murdoch BM;
    Front Genet; 2021; 12():628849. PubMed ID: 34093640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.
    Yuan C; Chen H; Tu S; Huang HY; Pan Y; Gui X; Kuang M; Shen X; Zheng Q; Zhang Y; Cheng C; Hong H; Tao X; Peng Y; Yao X; Meng F; Ji H; Shao Z; Sun Y
    Genome Biol; 2021 May; 22(1):156. PubMed ID: 34001209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique chromatin signature uncovers early developmental enhancers in humans.
    Rada-Iglesias A; Bajpai R; Swigut T; Brugmann SA; Flynn RA; Wysocka J
    Nature; 2011 Feb; 470(7333):279-83. PubMed ID: 21160473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Characterisation of Putative Enhancer Elements in Mouse Embryonic Stem Cells.
    Mantsoki A; Parussel K; Joshi A
    Bioinform Biol Insights; 2021; 15():1177932220974623. PubMed ID: 33623376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.
    Ho SWT; Sheng T; Xing M; Ooi WF; Xu C; Sundar R; Huang KK; Li Z; Kumar V; Ramnarayanan K; Zhu F; Srivastava S; Isa ZFBA; Anene-Nzelu CG; Razavi-Mohseni M; Shigaki D; Ma H; Tan ALK; Ong X; Lee MH; Tay ST; Guo YA; Huang W; Li S; Beer MA; Foo RSY; Teh M; Skanderup AJ; Teh BT; Tan P
    Gut; 2023 Feb; 72(2):226-241. PubMed ID: 35817555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.